150 related articles for article (PubMed ID: 34435746)
1. DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway.
Bai H; Song M; Jiao R; Li W; Zhao J; Xiao M; Jin M; Zhang Z; Deng H
J Cell Mol Med; 2021 Oct; 25(19):9306-9318. PubMed ID: 34435746
[TBL] [Abstract][Full Text] [Related]
2. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
[TBL] [Abstract][Full Text] [Related]
3. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
[No Abstract] [Full Text] [Related]
4. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
5. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
[TBL] [Abstract][Full Text] [Related]
6. EphA2 promotes tumorigenicity of cervical cancer by up-regulating CDK6.
Huang C; Chen Z; He Y; He Z; Ban Z; Zhu Y; Ding L; Yang C; Jeong JH; Yuan W; Yang L
J Cell Mol Med; 2021 Mar; 25(6):2967-2975. PubMed ID: 33586348
[TBL] [Abstract][Full Text] [Related]
7. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
Peng WX; Huang JG; Yang L; Gong AH; Mo YY
Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Diacylglycerol kinase zeta (DGKZ) suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest.
Liu K; Xue B; Bai G; Zhang W
Bioengineered; 2021 Dec; 12(1):1517-1529. PubMed ID: 33926342
[TBL] [Abstract][Full Text] [Related]
9. The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients.
Su YF; Wu TF; Ko JL; Tsai HT; Tee YT; Chien MH; Chou CH; Lin WL; Low HY; Chou MY; Yang SF; Wang PH
PLoS One; 2014; 9(3):e91644. PubMed ID: 24637958
[TBL] [Abstract][Full Text] [Related]
10. CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.
Barrón EV; Roman-Bassaure E; Sánchez-Sandoval AL; Espinosa AM; Guardado-Estrada M; Medina I; Juárez E; Alfaro A; Bermúdez M; Zamora R; García-Ruiz C; Gomora JC; Kofman S; Pérez-Armendariz EM; Berumen J
PLoS One; 2015; 10(9):e0137397. PubMed ID: 26372210
[TBL] [Abstract][Full Text] [Related]
11. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase D1 promotes cervical cancer progression by activating the RAS pathway.
Song M; Meng Q; Jiang X; Liu J; Xiao M; Zhang Z; Wang J; Bai H
J Cell Mol Med; 2022 Aug; 26(15):4244-4253. PubMed ID: 35775110
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway.
Hu YC; Wang AM; Lu JK; Cen R; Liu LL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5049-5055. PubMed ID: 29228418
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA GHET1 suppresses cervical carcinoma in vitro and in vivo.
Ling W; Yangchun X; Wei W; Qiang W
Cancer Biomark; 2020; 28(1):21-32. PubMed ID: 32176622
[TBL] [Abstract][Full Text] [Related]
15. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
16. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
Yang X; Feng KX; Li H; Wang L; Xia H
Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
[TBL] [Abstract][Full Text] [Related]
17. LINC01089 inhibits the progression of cervical cancer via inhibiting miR-27a-3p and increasing BTG2.
Li S; Han Y; Liang X; Zhao M
J Gene Med; 2021 Jan; 23(1):e3280. PubMed ID: 33025678
[TBL] [Abstract][Full Text] [Related]
18. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
20. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]